Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2008
10/08/2008CN101279021A Preparation of Pinellia ternata decoction pieces
10/08/2008CN101279017A Yunnan hongyao extract and extracting method thereof and application
10/08/2008CN101279003A Enema medicament for promoting anal exsufflation and preparation
10/08/2008CN101278995A Medicament for curing rhinorrhagia, gastrorrhagia and menoxenia
10/08/2008CN101278993A Method for extracting triterpenes from jujube fruit
10/08/2008CN101278991A Method for testing effective ingredients of Gegen Qinlian medicine
10/08/2008CN101278987A Chinese medicine compound for nourishing yin and tonifying kidney, benefiting-qi and promoting blood circulation, enriching blood and benefiting semen
10/08/2008CN101278982A Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same
10/08/2008CN101278978A Technique for preparing Forsythia volatile oil medicinal raw material and uses thereof
10/08/2008CN101278969A Method for preparing non-alkaloids part of subprostrate sophora root
10/08/2008CN101278966A Quality control method of phyllanthus urinaria oral preparation
10/08/2008CN101278965A Soft capsule of humifuse spurge and preparing method thereof
10/08/2008CN101278960A Medicament for curing icteric hepatitis using Farfugium japonicum and method
10/08/2008CN101278954A Ginseng or American ginseng product with increased content of ginseng saponin Rg3 and method of preparing the same
10/08/2008CN101278948A Biological medical membrane and method of preparing the same
10/08/2008CN101278938A Compound preparation of tenofovir and entecavir and its application against hepatitis B virus
10/08/2008CN101278921A Triopisetron Hydrochloride microcapsule and method for preparing injection
10/08/2008CN101278915A Medicament composition granule and method of preparing the same
10/08/2008CN101278912A Tetrandrine nanoemulsion injection and method of preparing the same
10/08/2008CN100424161C Wine and its brewing method
10/08/2008CN100424093C Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423768C A pharmaceutical composition for preventing or treating acute and chronic liver disease
10/08/2008CN100423743C Medicine for treating duodenal bulbar ulcer or inflammation
10/08/2008CN100423742C Chinese herbal medicine for treating gastropathy and its prepn process
10/08/2008CN100423722C Oral enteric micro-pills contg. pantoprazole or its salts and preparing process thereof
10/08/2008CN100423720C Dripping pills with silybin
10/08/2008CN100423717C Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
10/08/2008CN100423715C New pharmaceutical composition
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer
10/07/2008US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation
10/07/2008US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7431946 Method for producing extracts of Boehmeria frutescens thunberg or Boehmeria nivea for hepatitis treatment
10/07/2008US7431942 Orally disintegrable tablets
10/07/2008US7431931 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2362831C Thioamide derivatives
10/07/2008CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
10/07/2008CA2330256C Treatment of inflammatory bowel disease
10/07/2008CA2280715C Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
10/07/2008CA2179955C Kappa-opiate agonists for inflammatory bowel disorders
10/02/2008WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof
10/02/2008WO2008118092A1 Maleate salt of 3-bromo-n-{ (2s) -2- (4-f luorophenyl) -4- [3- (4-acetylpiperazin-1-yl) azetidin-1-yl] butyl} -methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders
10/02/2008WO2008118091A1 A fumarate salt of 3-bromo-n-{ (2s) -2- (4 -fluorophenyl) -4- [3- (4-acetylpiperazin-l-yl) azetidin-1-yl] butyl} -n-methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117767A1 Therapeutic agent for infectious skin or mucosal disease
10/02/2008WO2008117730A1 Composition for preventing or treating lung disease
10/02/2008WO2008117282A1 Polymorph of granisetron base and production process therefor
10/02/2008WO2008116708A1 Reduction of risk of diarrhoea
10/02/2008WO2008116385A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
10/02/2008WO2008073958A3 Substituted benzothiadiazinedioxide derivatives and methods of their use
10/02/2008US20080242732 Administering pharmaceutical orally at dose-delivery rate sufficient to provide clinically effective blood level in portal vein, less than required for blood level in peripheral circulation to provide dose-delivery selective in liver
10/02/2008US20080242723 for treating or preventing diseases or disorders such as spasticity or gastroesophageal reflux disease; oral dosage formulation
10/02/2008US20080242720 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
10/02/2008US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders
10/02/2008US20080242696 Mixing with a solvent and heating
10/02/2008US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241283 Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same
10/02/2008US20080241246 Cell-based therapies for treating liver disease
10/02/2008US20080241231 Transdermal delivery of dexamethasone and promethazine
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241081 Amide compound or salt thereof, and biofilm remover containing the same
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2682763A1 Methods and kits for administering probiotics
10/02/2008CA2681593A1 Preventive or therapeutic composition for liver disease
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/02/2008CA2678525A1 Reduction of risk of diarrhoea
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974744A1 Immunization through oral administration of a vaccine with an edible product
10/01/2008EP1974735A1 Reduction of risk of diarrhoea
10/01/2008EP1974730A1 Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
10/01/2008EP1974016A2 Mesenchymal stem cells and uses therefor
10/01/2008EP1973886A2 Prokineticin 1 receptor antagonists
10/01/2008EP1973607A1 Methods for altering stool quality and/or stool frequency
10/01/2008EP1973536A2 Treatment of fatty liver
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008EP1317274B1 Peptide composition for treatment of periodontal diseases and prevention of skin aging
10/01/2008EP1274686B1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl proprionic acid
10/01/2008CN101277687A Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
10/01/2008CN101275158A Screening preparation for superior enterococcus faecalis and application thereof
10/01/2008CN101275124A Recombinant bacterial phytases and uses thereof
10/01/2008CN101275111A Formula of physical-fatigue-relieving, kidney-tonifying Yang-establishing health wine and preparation thereof
10/01/2008CN101275110A Formula of blood-nourishing Yin-nourishing health wine and preparation thereof
10/01/2008CN101275108A Formula of blood-nourishing skin-whitening health wine and preparation thereof